MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about secretarial compliance report

26 May 2026 Evaluate
In compliance with the provisions of Regulation 24A of SEBI LODR Amendment Regulations, 2018, read with SEBI Circular dated February 08, 2019, GlaxoSmithKline Pharmaceuticals has informed that it enclosed Annual Secretarial Compliance Report of the Company for the financial year ended 31st March 2026.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1146.00
Cipla 1360.00
Lupin 2046.00
Zydus Lifesciences 1106.10
View more..